{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:44:49Z","timestamp":1761579889612},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1067\/mhj.2000.107174","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:17:12Z","timestamp":1027570632000},"page":"437-444","source":"Crossref","is-referenced-by-count":28,"title":["Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: A placebo-controlled, multicenter study"],"prefix":"10.1067","volume":"140","author":[{"given":"Kaoru","family":"Okishige","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Nishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Azegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Yamawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Aonuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2000.107174_bib1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiologic features of chronic atrial fibrillation. The Framingham study","volume":"306","author":"Kannel","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.107174_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.me.39.020188.000353","article-title":"Atrial fibrillation: natural history, complications and management","volume":"39","author":"Alpert","year":"1988","journal-title":"Ann Rev Med"},{"key":"10.1067\/mhj.2000.107174_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.51.2.251","article-title":"Effect of digoxin on atrioventricular conduction studies on patients with and without cardiac autonomic innervation","volume":"51","author":"Goodman","year":"1975","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.107174_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-114-7-573","article-title":"Digoxin for atrial fibrillation: a drug whose time has gone?","volume":"114","author":"Falk","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1067\/mhj.2000.107174_bib5","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/0002-9149(79)90456-9","article-title":"Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta-adrenergic blocking agent","volume":"44","author":"David","year":"1975","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0002-8703(86)90551-X","article-title":"The esmolol vs placebo multicenter study group: comparison of the efficacy and safety of esmolol, a short-acting \u03b2-blocker, with placebo in the treatment of supraventricular tachyarrhythmias","volume":"111","author":"Anderson","year":"1986","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2000.107174_bib7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0002-8703(84)90592-1","article-title":"Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin","volume":"108","author":"DiBianco","year":"1984","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2000.107174_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0735-1097(87)80013-X","article-title":"Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation","volume":"10","author":"Atwood","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1378\/chest.83.3.491","article-title":"Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation","volume":"83","author":"Lang","year":"1983","journal-title":"Chest"},{"key":"10.1067\/mhj.2000.107174_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0735-1097(87)80396-0","article-title":"Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise","volume":"9","author":"Steinberg","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/0002-9149(91)90885-O","article-title":"Effects of intravenous diltiazem on rapid atrial fibrillation accompanied by congestive heart failure","volume":"67","author":"Heywood","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0735-1097(90)90649-A","article-title":"Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs","volume":"15","author":"Antman","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0002-9149(91)90828-9","article-title":"Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter","volume":"68","author":"Crijins","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0002-9149(88)90373-6","article-title":"Propafenone for prevention of recurrent atrial fibrillation","volume":"45","author":"Kerr","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib15","doi-asserted-by":"crossref","first-page":"11A","DOI":"10.1016\/0002-9149(92)91072-C","article-title":"Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience","volume":"70","author":"Anderson","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib16","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1540-8159.1993.tb02329.x","article-title":"Efficacy of type Ic antiarrhythmic agents for treatment of resistant atrial fibrillation","volume":"16","author":"Grey","year":"1993","journal-title":"PACE"},{"key":"10.1067\/mhj.2000.107174_bib17","doi-asserted-by":"crossref","first-page":"24C","DOI":"10.1016\/0002-9149(90)90111-D","article-title":"Thromboembolic complications of atrial fibrillation and their prevention: a review","volume":"65","author":"Peterson","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib18","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/01.CIR.92.8.2178","article-title":"Silent cerebral infarction in patients with nonrheumatic atrial fibrillation","volume":"92","author":"Ezekowitz","year":"1995","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.107174_bib19","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.CIR.82.6.1932","article-title":"Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation","volume":"82","author":"Juul-Moller","year":"1990","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.107174_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7326\/0003-4819-120-6-199403150-00001","article-title":"Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone","volume":"120","author":"Disch","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1067\/mhj.2000.107174_bib21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/00005344-198609000-00017","article-title":"Electrophysiological actions of N-(2,6-dimethylphenyl)-8-pyrrolizidine-acetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent","volume":"8","author":"Hattori","year":"1986","journal-title":"J Cardiovasc Phannacol"},{"key":"10.1067\/mhj.2000.107174_bib22","first-page":"1239","article-title":"N-(2,6-dimetylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent","volume":"35","author":"Aisaka","year":"1985","journal-title":"Arzneim Forsch"},{"key":"10.1067\/mhj.2000.107174_bib23","first-page":"1381","article-title":"N-(2,6-dimetylphenyl)-8-pyrrolizineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction","volume":"35","author":"Hidaka","year":"1985","journal-title":"Arzneim Forsch"},{"key":"10.1067\/mhj.2000.107174_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1536\/ihj.34.301","article-title":"Effects of pilsicainide on the atrial fibrillation threshold in guinea pig atria: a comparative study with disopyramide, lidocaine and flecainide","volume":"34","author":"Inoue","year":"1993","journal-title":"Jpn Heart J"},{"key":"10.1067\/mhj.2000.107174_bib25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0002-9149(96)00401-8","article-title":"Conversion of recent-onset atrial fibrillation by a single oral dose of pilsicainide (Pilsicainide SuppressionT on Atrial Fibrillation)","volume":"78","author":"Atarashi","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0735-1097(89)90074-0","article-title":"Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation","volume":"14","author":"Stanton","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"10.1067\/mhj.2000.107174_bib28","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/archinte.1990.00040031598006","article-title":"Atrial fibrillation","volume":"150","author":"Wipf","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1067\/mhj.2000.107174_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"key":"10.1067\/mhj.2000.107174_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1476-5381.1993.tb13448.x","article-title":"Antiarrhythmic agents act differently on the activation phase of the Ach-response in guinea-pig myocytes","volume":"108","author":"Inomam","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1067\/mhj.2000.107174_bib31","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0735-1097(95)00286-5","article-title":"Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of somlol versus quinidine","volume":"26","author":"Hohnloser","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib32","doi-asserted-by":"crossref","first-page":"50A","DOI":"10.1016\/0002-9149(92)91078-I","article-title":"Efficacy of flecainide for the reversion of acute onset atrial fibrillation","volume":"70","author":"Donovan","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0002-9149(89)90284-1","article-title":"Echocardiographic and clinical predictors for outcome of elective cardioversion in atrial fibrillation","volume":"63","author":"Dittrich","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0735-1097(96)00439-1","article-title":"Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study","volume":"29","author":"Omran","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0002-9149(88)90373-6","article-title":"Propafenone for prevention of recurrent atrial fibrillation","volume":"61","author":"Kerr","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9149(96)00779-5","article-title":"Propafenone for conversion and prophylaxis of atrial fibrillation","volume":"79","author":"Stroobandt","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib37","first-page":"465","article-title":"Evaluation of pilsicainide hydrochloride on efficacy and safety on paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation or flutter","volume":"20","author":"Ogawa","year":"1992","journal-title":"Jpn Pharmacol Ther"},{"key":"10.1067\/mhj.2000.107174_bib38","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0735-1097(96)00230-6","article-title":"Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study","volume":"28","author":"Biankoni","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00823592","article-title":"Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study","volume":"10","author":"Crijins","year":"1996","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1067\/mhj.2000.107174_bib40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.CIR.53.2.273","article-title":"Relation between echocardiographically determined left atrial size and atrial fibrillation","volume":"53","author":"Henry","year":"1976","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.107174_bib41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/hrt.44.5.589","article-title":"Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm","volume":"44","author":"Halpern","year":"1980","journal-title":"Br Heart J"},{"key":"10.1067\/mhj.2000.107174_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-65-2-216","article-title":"Electrical cardioversion of atrial fibrillation. Immediate and long-term results and selection of patients","volume":"65","author":"Morns","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1067\/mhj.2000.107174_bib43","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0735-1097(93)90543-A","article-title":"Impact of electrical cardioversion of atrial fibrillation on left atrial appendage function and smoke: characterization by simultaneous transesophageal echocardiography","volume":"22","author":"Grimm","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0735-1097(94)90412-X","article-title":"Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for atrial stunning as a mechanism of thromboembolic complications","volume":"23","author":"Fatkin","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9149(96)00333-5","article-title":"Transesophageal echocardiography evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation","volume":"78","author":"Falcone","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2000.107174_bib46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2000.107174_bib47","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.82.4.1106","article-title":"Efficacy and safety of quinidine therapy for maintenance of sinus rhythm alter cardioversion. A meta-analysis of randomized controlled trials","volume":"82","author":"Coplen","year":"1990","journal-title":"Circulation"},{"key":"10.1067\/mhj.2000.107174_bib48","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0002-9149(93)90511-A","article-title":"Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation","volume":"71","author":"Reimold","year":"1993","journal-title":"Am J Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870300477185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870300477185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T13:55:49Z","timestamp":1557410149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870300477185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0002870300477185"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2000.107174","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}